Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer

Strahlentherapie und Onkologie

Volumn 190, Issue 2, 2014, Pages 192-198

  Haderlein, M ^a   Semrau, S ^a   Ott, O ^a   Speer, S ^a   Bohr, C ^a   Fietkau, R ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Dose; Dysphagia; Head and neck cancer; Organs at risk; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT;

ALCOHOL ABUSE; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; DYSPHAGIA; FEMALE; FOLLOW UP; HUMAN; HYPOPHARYNX CANCER; INDUCTION CHEMOTHERAPY; LARYNX CANCER; MALE; OROPHARYNX CANCER; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; RADIATION DOSE; RADIOTHERAPY PLANNING SYSTEM; RETROSPECTIVE STUDY; RISK FACTOR; SOFT PALATE; SWALLOWING; TRACHEOTOMY; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; ALCOHOLISM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; DEGLUTITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893789521     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0493-0     Document Type: Article

References (26)

1. Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31(7):845-852
2. Eisbruch A, Kim HM, Feng FY et al (2011) Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys 81(3):e93-e99
3. Caudell JJ, Schaner PE, Desmond RA et al (2010) Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 76(2):403-409
4. Teguh DN, Levendag PC, Noever I et al (2008) Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 72(4):1119-1127
5. Levendag PC, Teguh DN, Voet P et al (2007) Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 85(1):64-73
6. Schwartz DL, Hutcheson K, Barringer D et al (2010) Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 78(5):1356-1365
7. Deantonio L, Masini L, Brambilla M et al (2013) Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles. Strahlenther Onkol 189(3):230-236
8. Dirix P, Abbeel S, Vanstraelen B et al (2009) Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 75(2):385-392
9. Caglar HB, Tishler RB, Othus M et al (2008) Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 72(4):1110-1118
10. Li B, Li D, Lau DH et al (2009) Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol 4:52
11. Jensen K, Lambertsen K, Grau C (2007) Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 85(1):74-82
12. Caudell JJ, Schaner PE, Meredith RF et al (2009) Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 73(2):410-415
13. Semrau S, Schmidt D, Lell M et al (2013) Results of chemoselection with short induction chemotherapy followed by chemoradiation or surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx. Oral Oncol 49(5):454-460
14. Semrau S, Waldfahrer F, Lell M et al (2011) Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results. Strahlenther Onkol 187(1):15-22
15. Christianen ME, Langendijk JA, Westerlaan HE et al (2011) Delineation of organs at risk involved in swallowing for radiotherapy treatment. Radiother Oncol 101(3):394-402
16. Blanchard P, Baujat B, Holostenco V et al (2011) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 100(1):33-40
17. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM et al (2008) Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 26(22):3770-3776
18. Logemann JA, Pauloski BR, Rademaker AW et al (2008) Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 30(2):148-158
19. Maurer J, Hipp M, Schäfer C, Kölbl O (2011) Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer. Strahlenther Onkol 187(11):744-749
20. Tribius S, Sommer J, Prosch C et al (2013) Xerostomia after radiotherapy. What matters - mean total dose or dose to each parotid gland? Strahlenther Onkol 189(3):216-222
21. Schwartz DL (2012) Current progress in adaptive radiation therapy for head and neck cancer. Curr Oncol Rep 14(2):139-147
22. Hu CC, Huang WT, Tsai CL et al (2011) Practically acquired and modified cone-beam computed tomography images for accurate dose calculation in head and neck cancer. Strahlenther Onkol 187(10):633-644
23. Nutting CM, Morden JP, Harrington KJ et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127-136
24. Feng FY, Kim HM, Lyden TH et al (2010) Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 28(16):2732-2738
25. Damast S, Wolden S, Lee N (2012) Marginal recurrences after selective targeting with intensitymodulated radiotherapy for oral tongue cancer. Head Neck 34(6):900-906
26. Chen AM, Farwell DG, Luu Q et al (2011) Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 80(5):1423-1429